Greenstreet Yvonne's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Jun 3, 2025
- Accession no.
- 0001735276-25-000075
- Filed
- Jun 3, 2025
- Trade date
- May 30-Jun 2, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $15.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Greenstreet YvonneCIK 0001446125 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | MOption exerciseAcquired | +12,081 | $119.13 | +$1,439,209.53 | 61,029 | Direct | |
| May 30, 2025 | Common Stock | MOption exerciseAcquired | +19,559 | $118.05 | +$2,308,939.95 | 80,588 | Direct | |
| May 30, 2025 | Common Stock | SSaleDisposed | −25,469 | $304.00 | −$7,742,576 | 55,119 | Direct | |
| May 30, 2025 | Common Stock | SSaleDisposed | −6,171 | $306.00 | −$1,888,326 | 48,948 | Direct | |
| Jun 2, 2025 | Common Stock | MOption exerciseAcquired | +12,080 | $119.13 | +$1,439,090.4 | 61,028 | Direct | |
| Jun 2, 2025 | Common Stock | MOption exerciseAcquired | +7,217 | $118.05 | +$851,966.85 | 68,245 | Direct | |
| Jun 2, 2025 | Common Stock | SSaleDisposed | −19,297 | $306.00 | −$5,904,882 | 48,948 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | MOption exerciseDisposed | −19,559 | $0.00 | $0 | 8,064 | Direct | |
| Jun 2, 2025 | Common Stock | MOption exerciseDisposed | −7,217 | $0.00 | $0 | 847 | Direct | |
| May 30, 2025 | Common Stock | MOption exerciseDisposed | −12,081 | $0.00 | $0 | 12,919 | Direct | |
| Jun 2, 2025 | Common Stock | MOption exerciseDisposed | −12,080 | $0.00 | $0 | 839 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.